Investitionsthese
Helsana HealthInvest AG invests in scalable start-ups with traction, targeting the Swiss market and broader DACH/Benelux/Nordics regions, excluding biotech, life sciences, and pharma.
Investitionsphase
Series A to B
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Start-ups improving patient access to healthcare, fintech, insurtech, and cybersecurity
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
€1.000.000 - €5.000.000
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
Investment Team (11)
B
Barbara Langsdorf
Investment Manager
B
Beat Riedle
Team Member
D
Dietrich Aumann
Investment Manager
D
Dr. Elisabeth Bourqui
Chair of the Board
D
Dr. Ralf Molitor
Managing Director
D
Dr. Ulrich Geilinger
Team Member
E
Elisabeth Bourqui
Investment Professional
R
Ralf Molitor
Managing Director
R
Roman Schuppisser
Board Member
U
Ulrich Geilinger
Investment Professional
Y
Yannick Bomhard
Investment Manager
